Does body mass index at diagnosis or weight change during therapy predict toxicity or survival in intermediate risk rhabdomyosarcoma? A report from the Children's Oncology Group soft tissue sarcoma committee

Megan E. Burke, Elizabeth R. Lyden, Jane L. Meza, Elena J. Ladas, Roshni Dasgupta, Ellen A. Wiegner, Carola A.S. Arndt

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Fingerprint

Dive into the research topics of 'Does body mass index at diagnosis or weight change during therapy predict toxicity or survival in intermediate risk rhabdomyosarcoma? A report from the Children's Oncology Group soft tissue sarcoma committee'. Together they form a unique fingerprint.

Medicine & Life Sciences